The advertisement promotes QUVIVQ (daridorexant) as a treatment for adult patients with insomnia, highlighting its mechanism of action and half-life.
Creative Information
| CID: | 134a0b0d-2ff0-4469-9069-beb122db1e4c |
| CRID: | 92_5528:235043 |
| Domain: | idorsia.com |
| Seat: | RBC |
| Size: | 728x90 |
| Bid: | $2.08 |
| Timestamp: | 11/17/2025, 6:03:48 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/17/2025, 7:35:09 PM | 5.57s | |
| adomain_analysis | success | 11/17/2025, 7:36:37 PM | 3.31s | |
| adomain_capture | success | 11/17/2025, 7:36:34 PM | 0.18s | |
| ad_render | success | 11/17/2025, 7:35:04 PM | 11.11s | |
| brand_mapping | success | 11/17/2025, 6:03:49 PM | 0.47s | |
Analysis Results
Ad Format: banner
Brands: Idorsia
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 1266.75 KB | ||||||||||||||||||||||
| Render Time: | 9.78 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Total Ad Size: | 1266.96 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain
Ad Preview
Raw Ad Markup
<div data-rp-type="trp-display-creative" data-rp-impression-id="94120269-3d84-4d97-bea8-7539e0ec8a49" data-rp-aqid="5528:235043" data-rp-acct-id="11864"><div style="width: 0; height: 0; overflow: hidden;"><img border="0" width="1" height="1" src="https://useast-beacon.deepintent.com/impression/d26537cd-8e4f-70a9-07f0-477d5df97c99?ts=1762993008433&wp=AC02873F17555939" alt="" /><img border="0" width="1" height="1" src="https://beacon-iad6.rubiconproject.com/beacon/d/94120269-3d84-4d97-bea8-7539e0ec8a49?oo=0&accountId=11864&siteId=229562&zoneId=1708178&sizeId=2&e=6A1E40E384DA563B63A3DF863742C8134D76F516BDF4D35DD810256E47A5CAF7F867BB91126602DCC2B4DAA9CC290CB13195AAF847E7A048EC8E7E0EED729549F184340AD3C83CF15FC5B167DD54DF0F891430121A396A93A565013C99FE89EC076B3B3529FACF36F66F2E3DCD7784AFF140509C5AB1CDA37A16D67E856233F6DB36492CD3B0E6352FA4D20406114B96EB41817CE69848DCD571918B117EC07D28866E2A7361E814FFD2A6AEE62715F2323609EDB10428B3" alt="" /></div>
<span id='deepintent_wrapper_1' onclick=DeepIntentExecuteClicks('')><script type='text/javascript'>document.addEventListener('DOMContentLoaded',function(){setTimeout(function(){new Image().src='https://useast-beacon.deepintent.com/vi?impid=d26537cd-8e4f-70a9-07f0-477d5df97c99&spanlen='+ (document.getElementById('deepintent_wrapper_span_1-d285-41dc-aa10-d8eb1b8c7bc7').innerHTML.length) + '&spanelemcnt=' + (document.getElementById('deepintent_wrapper_span_1-d285-41dc-aa10-d8eb1b8c7bc7').getElementsByTagName('*').length);},3000)});</script><span id='deepintent_wrapper_span_1-d285-41dc-aa10-d8eb1b8c7bc7'><ins class='dcmads' style='display:inline-block;width:728px;height:90px' data-dcm-placement='N1212560.3971531SYNEOS_USA_5359/B33104206.426957711' data-dcm-rendering-mode='script' data-dcm-landing-page-escapes='2' data-dcm-click-tracker='https://useast-beacon.deepintent.com/click/d26537cd-8e4f-70a9-07f0-477d5df97c99?ts=1762993008433&wp=AC02873F17555939&loc=1&r=' data-dcm-https-only data-dcm-api-frameworks='[APIFRAMEWORKS]' data-dcm-omid-partner='[OMIDPARTNER]' data-dcm-gdpr-applies='gdpr=' data-dcm-gdpr-consent='gdpr_consent=' data-dcm-addtl-consent='addtl_consent=${ADDTL_CONSENT}' data-dcm-ltd='false' data-dcm-resettable-device-id='' data-dcm-app-id=''> <script src='https://www.googletagservices.com/dcm/dcmads.js'></script></ins></span><script type="text/javascript"src="https://pixel.adsafeprotected.com/jload?anId=931578&impId=d26537cd-8e4f-70a9-07f0-477d5df97c99&advId=11569&campId=217185&pubId=10067&dealId=&placementId=426957711&chanId=235043&bidurl=[EXT_BID_URL]&planId=[EXT_PLAN_ID]&adsafe_par"></script><script src="https://cdn.doubleverify.com/dvtp_src.js?ctx=20515845&cmp=DV973873&sid=deepintent&plc=deepintent_im_disp_js&adsrv=0&advid=3891363&ppid=118&dvtagver=6.1.src&aufilter1=IM&autt=1&auevent=d26537cd-8e4f-70a9-07f0-477d5df97c99&aubndl=&pltfrm=10067&auip=145.224.5.226&DVPX_PP_AUCTION_UA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F142.0.0.0+Safari%2F537.36+Edg%2F142.0.0.0&turl=https%3A%2F%2Fwww.cnn.com%2F" type="text/javascript"></script></span><script type='text/javascript'>window.DeepIntentExecuteClicks=window.DeepIntentExecuteClicks||function(e){if(e)for(var n=e.split(','),t=0;t<n.length;t++)if(n[t])(new Image).src=n[t]};</script><noscript><img src='https://useast-beacon.deepintent.com/impression/d26537cd-8e4f-70a9-07f0-477d5df97c99?ts=1762993008433&wp=TRACK' height='0px' width='0px' style='display:none' referrerpolicy='no-referrer-when-downgrade'></noscript><script type="text/javascript">(function(){var r;try{r=window.location.ancestorOrigins[window.location.ancestorOrigins.length-1];}catch(e){}new Image().src='https://useast-beacon.deepintent.com/impression/d26537cd-8e4f-70a9-07f0-477d5df97c99?ts=1762993008433&wp=TRACK'+((typeof r==='string')?'&rf='+r:'');})();</script><iframe src='https://cdn.deepintent.com/syncpixel.html?_di_cfg=a' width='0' height='0' style='display:none;'></iframe><div style="width: 0; height: 0; overflow: hidden;"><img border="0" width="1" height="1" src="https://token.rubiconproject.com/register?khaos=MHWOINF9-4-FVTK" alt="" /></div>
</div><div style="height:0px;width:0px;overflow:hidden"><iframe src="https://eus.rubiconproject.com/usync.html?&geo=na&co=us" frameborder="0" marginwidth="0" marginheight="0" scrolling="NO" width="0" height="0" style="height:0px;width:0px"></iframe></div>
Creatives
